title: Estrogen-induced expression of Fos-related antigen 1 (FRA-1) regulates uterine stromal differentiation and remodeling.
abstract: Concerted actions of estrogen and progesterone via their cognate receptors orchestrate changes in the uterine tissue, regulating implantation during early pregnancy. The uterine stromal cells undergo steroid-dependent differentiation into morphologically and functionally distinct decidual cells, which support embryonic growth and survival. The hormone-regulated pathways underlying this unique cellular transformation are not fully understood. Previous studies in the mouse revealed that, following embryo attachment, de novo synthesis of estrogen by the decidual cells is critical for stromal differentiation. In this study we report that Fos-related antigen 1 (FRA-1), a member of the Fos family of transcription factors, is a downstream target of regulation by intrauterine estrogen. FRA-1 expression was localized in the differentiating uterine stromal cells surrounding the implanted embryo. Attenuation of estrogen receptor α (Esr1) expression by siRNA mediated silencing in primary uterine stromal cells suppressed FRA-1 expression. Furthermore, chromatin immunoprecipitation demonstrated direct recruitment of ESR1 to an estrogen response element in the Fra-1 promoter. Down-regulation of Fra-1 expression during in vitro decidualization blocked stromal differentiation and resulted in a marked decrease in stromal cell migration. Interestingly, FRA-1 controls the expression of matrix metalloproteinases MMP9 and MMP13, which are critical modulators of stromal extracellular matrix remodeling. Collectively, these results suggest that FRA-1, induced in response to estrogen signaling via ESR1, is a key regulator of stromal differentiation and remodeling during early pregnancy.
authors.affiliation: Department of Comparative Biosciences, University of Illinois at Urbana-Champaign, Urbana, Illlinois 61802, USA.
authors.forename: Amrita
authors.initials: A
authors.lastname: Das
authors.forename: Quanxi
authors.initials: Q
authors.lastname: Li
authors.forename: Mary J
authors.initials: MJ
authors.lastname: Laws
authors.forename: Hatice
authors.initials: H
authors.lastname: Kaya
authors.forename: Milan K
authors.initials: MK
authors.lastname: Bagchi
authors.forename: Indrani C
authors.initials: IC
authors.lastname: Bagchi
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D010064:Embryo Implantation / Q000502:physiology; D047628:Estrogen Receptor alpha / Q000235:genetics / Q000378:metabolism*; D004967:Estrogens / Q000378:metabolism*; D005260:Female; D015971:Gene Expression Regulation, Enzymologic / Q000502:physiology; D008297:Male; D053509:Matrix Metalloproteinase 13 / Q000096:biosynthesis; D020780:Matrix Metalloproteinase 9 / Q000096:biosynthesis; D051379:Mice; D011247:Pregnancy / Q000378:metabolism*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism; D014599:Uterus / Q000166:cytology / Q000378:metabolism*; D000099169:Fos-Related Antigen 1
chemical_list: D047628:Estrogen Receptor alpha; D004967:Estrogens; D053509:Matrix Metalloproteinase 13; D020780:Matrix Metalloproteinase 9; D016760:Proto-Oncogene Proteins c-fos; D000099169:Fos-Related Antigen 1; C507081:Mmp13 protein, mouse; C501830:Mmp9 protein, mouse